I’ve been watching the market chatter around artificial intelligence for months now, and something feels different lately. The excitement hasn’t vanished, but the easy gains that once seemed almost automatic are starting to look a little less certain. Higher borrowing costs, rising energy prices, and questions about how long companies can keep pouring money into data centers have quietly shifted the conversation. If you’re feeling that same unease, you’re not alone. A growing number of investors are asking what happens if the AI growth story cools faster than expected.
Why Defensive Stocks Deserve a Fresh Look Right Now
After a stretch of intense pressure from interest rates, equity markets have begun to dial back their most optimistic growth forecasts. Positioning has lightened, and the gap between cyclical names and more defensive ones has widened noticeably. In just a couple of weeks that relative pair dropped several percentage points. Credit markets and rate-sensitive assets have shown similar strain. None of this means the AI infrastructure build-out is finished. It does suggest the easy phase of the trade may be behind us.
Analysts estimate that AI-related capital spending has been responsible for roughly half of recent earnings growth in the broad market. That contribution is expected to fade as the pace of spending growth slows. The base case still calls for continued overall earnings expansion. Yet the probability of a rotation into more defensive areas has risen. Household spending could eventually benefit from lower energy costs and easier financing conditions later on, but the nearer-term picture looks cloudier.
In my view, the smartest response isn’t panic. It’s selective preparation. Investors who want to protect against a weaker outcome should lean toward companies that display quality characteristics and operate in industries less dependent on rapid economic acceleration. Health care and consumer staples stand out because demand for their products tends to hold up even when discretionary spending slows.
The Case for Playing Defense Without Abandoning Growth
Defensive investing often gets a bad reputation. People hear the word and picture sleepy portfolios that lag for years. That stereotype misses the point. Quality defensive names can still deliver solid returns, especially when they have been left behind during a growth-heavy rally. Many of these stocks now trade at valuations that look reasonable relative to their free cash flow generation.
Free cash flow yield is a particularly useful metric in the current environment. It tells you how much cash a company produces after necessary capital spending, relative to its market value. Higher yields can signal either undervaluation or strong underlying profitability. When combined with stable demand and a healthy dividend, the combination becomes appealing for investors who want both income and potential upside if sentiment rotates.
I’ve found that the best defensive candidates share a few common traits. They generate consistent cash, they have manageable debt levels relative to that cash, and they operate in businesses where customers keep buying even when headlines turn cautious. The recent lag in some of these names creates what analysts describe as a possible catch-up opportunity if growth expectations continue to moderate.
Tyson Foods: High Cash Flow Yield in a Stable Industry
One name that consistently appears on quality defensive screens is Tyson Foods. The company has delivered an impressive trailing free cash flow yield near 11 percent, among the highest in the group of stocks that meet these criteria. Shares have declined nearly 17 percent over the past six months, leaving the valuation more attractive than it has been for some time. The dividend yield sits around 3.7 percent, providing a meaningful income cushion while investors wait for any potential re-rating.
Food and beverage companies rarely deliver the kind of explosive growth that technology names can produce during a boom. What they offer instead is resilience. People still need to eat when economic uncertainty rises. Input cost pressures can create short-term margin challenges, yet management teams that navigate those pressures carefully often emerge with stronger competitive positions. Tyson’s ability to generate substantial free cash even during a period of share price weakness is noteworthy.
Of course, no stock is without risk. Commodity price swings, labor costs, and shifting consumer preferences toward alternative proteins all matter. Still, the combination of high free cash flow yield and a solid dividend makes the name worth closer examination for anyone building a more defensive sleeve in their portfolio. In my experience, these kinds of lagged quality names often surprise to the upside once the market starts rewarding stability again.
CVS Health: Attractive Cash Generation After Recent Weakness
CVS Health also screens well on free cash flow metrics, posting a yield near 9 percent. The stock has advanced roughly 15 percent year to date, yet it has pulled back about 15 percent over the past three months. That recent softness has improved the entry point for longer-term investors. The dividend yield currently stands near 2.9 percent.
Health care remains one of the more defensive sectors for good reason. Demand for pharmacy services, health benefits, and related offerings tends to persist through economic cycles. CVS operates across several segments that benefit from this structural demand. Challenges around reimbursement rates, integration of past acquisitions, and competitive pressures in retail pharmacy are real, but the underlying cash generation capacity has remained solid.
What draws attention here is the combination of improved valuation after the recent decline and the company’s ability to produce cash that can support both the dividend and potential reinvestment. For investors concerned that AI-related spending growth may slow, names like this offer a different earnings trajectory that is less tied to the capital expenditure cycle in technology.
Investors concerned about a weaker outcome should focus on stocks in defensive industries with quality attributes.
That guidance captures the current mood among many professional investors. Quality attributes typically include strong balance sheets, consistent free cash flow, and businesses that do not require perfect economic conditions to thrive. Both of the names discussed above fit that description reasonably well.
Understanding the Broader Market Shift
The recent pressure on cyclical stocks relative to defensive ones did not appear out of nowhere. Months of rising rates gradually increased the cost of capital. Equity markets began to reflect more cautious growth assumptions. Positioning adjustments amplified the moves. When investors lighten exposure to the most expensive growth stories, capital has to go somewhere. Historically, some of that capital finds its way into higher-quality, more stable businesses that had been ignored during the prior phase.
AI capital spending remains an important driver, yet its contribution to overall market earnings growth is projected to diminish as the rate of increase slows. This does not require a collapse in AI investment. Even a simple moderation in the growth rate can change relative performance patterns across sectors. Energy prices and financing costs add another layer of complexity to the near-term outlook.
Looking further ahead, some macroeconomic forecasts anticipate weaker energy prices and lower interest rates in 2027. Those conditions could eventually support household spending and benefit more consumer-facing companies. In the meantime, the defensive posture offers a way to stay invested while reducing sensitivity to any near-term disappointment in growth expectations.
How to Think About Portfolio Positioning
Building a more defensive allocation does not mean abandoning every growth name. It means adjusting the balance. Many long-term investors still want exposure to transformative technologies. The question becomes one of sizing and of pairing that exposure with ballast that can hold up better if the growth narrative softens.
One practical approach is to screen for companies that combine the following characteristics:
- Elevated free cash flow yields relative to recent history and sector peers
- Stable or growing dividends that appear sustainable based on cash generation
- Business models less sensitive to rapid changes in capital spending cycles
- Recent underperformance that has improved valuation without destroying the underlying franchise
- Manageable leverage relative to free cash flow
These criteria are not guarantees of future performance. They simply tilt the odds toward companies that can weather periods of uncertainty more comfortably. I have watched similar rotations play out in previous cycles. The names that looked dull during the peak of growth enthusiasm sometimes delivered the steadier results once the market’s focus shifted.
Risks That Still Deserve Attention
No strategy is risk-free. Defensive stocks can still decline if the overall market sells off sharply. They can also lag for extended periods if growth re-accelerates more strongly than expected. Company-specific issues matter too. Operational missteps, regulatory changes, or unexpected cost pressures can affect even the most stable businesses.
Interest rate paths remain uncertain. Energy markets can move quickly. Consumer behavior continues to evolve. Any of these factors could influence the relative performance of health care and consumer staples versus technology and other cyclical areas. The goal is not to predict every twist perfectly. It is to construct a portfolio that can adapt as new information arrives.
Perhaps the most interesting aspect of the current setup is the degree to which some quality defensive names have lagged. That lag creates room for a catch-up trade if investors continue to reduce growth expectations. Whether that trade materializes in the coming months or takes longer remains an open question. What feels clearer is that ignoring the possibility entirely leaves portfolios more exposed than necessary.
Practical Steps for Individual Investors
Start by reviewing the current sector weights in your portfolio. If technology and other high-growth areas dominate, consider whether a modest increase in health care or consumer staples exposure would improve balance. Look beyond headline price performance. Focus on free cash flow trends, dividend sustainability, and the competitive position of each business.
Dollar-cost averaging into any new positions can reduce the risk of poor timing. Rebalancing periodically helps lock in gains from areas that have run hard and redeploy capital into areas that look more reasonably valued. Tax considerations matter as well, especially in taxable accounts. Sometimes the most efficient way to increase defensive exposure is through new contributions rather than large sales of existing holdings.
I have found that writing down the reasons for each position helps maintain discipline. If a stock was purchased for its free cash flow yield and defensive characteristics, temporary underperformance relative to high-flying growth names becomes easier to tolerate. The opposite is also true. If the original thesis no longer holds, it becomes easier to move on.
Longer-Term Perspective on AI and Market Leadership
Artificial intelligence is not going away. The technology continues to advance, and capital spending in related infrastructure remains substantial. The more relevant question for portfolio construction is whether that spending will continue to drive such a large share of overall market earnings growth. History suggests that leadership rotates. Periods of intense focus on one theme eventually give way to broader participation.
When that rotation occurs, the companies that have quietly continued generating cash and returning capital to shareholders often attract renewed attention. Their valuations can expand even if absolute growth rates remain moderate. That dynamic has played out repeatedly across different market cycles. Recognizing it early can make a meaningful difference to long-term results.
Consumer staples and health care are not the only defensive areas. Utilities, certain telecommunications businesses, and select industrial names with stable cash flows can also play a role. The common thread is quality. Balance sheet strength, predictable demand, and the ability to generate cash through varying economic conditions matter more than any single sector label.
Balancing Income and Potential Upside
Many of the names that screen well on free cash flow also offer meaningful dividend yields. That income component provides a tangible return while investors wait for any potential multiple expansion. In a higher-rate environment, the relative attractiveness of equity income has shifted compared with recent years. Still, dividends that are well covered by free cash flow remain valuable.
The total return equation includes both income and capital appreciation. Defensive stocks that lag during growth-driven rallies can deliver stronger total returns once the market begins to reward stability. The key is identifying businesses whose competitive positions remain intact even after periods of share price weakness. Price declines that reflect temporary sentiment rather than permanent impairment of the franchise create opportunity.
In my experience, the most frustrating part of defensive positioning is the waiting. Growth names can continue to outperform for longer than feels comfortable. Maintaining conviction requires a clear framework and a willingness to accept periods of relative underperformance. The alternative—chasing whatever has worked most recently—often leads to buying high and selling low.
Putting It All Together
The current environment presents a classic tension between continued technological progress and rising questions about the pace of related investment. Analysts who have examined the situation closely suggest that investors worried about a softer outcome should emphasize quality defensive characteristics. Free cash flow yield, dividend support, and business model resilience form the core of that approach.
Names such as Tyson Foods and CVS Health illustrate the kinds of opportunities that appear when growth expectations moderate and previously overlooked stocks become more reasonably valued. Neither is perfect. Both face company-specific challenges. Yet both generate substantial cash relative to their current market prices and operate in industries with relatively stable demand.
Market leadership rarely stays concentrated forever. Preparing for a broader set of outcomes does not require abandoning belief in long-term innovation. It simply means acknowledging that the path is rarely linear and that quality businesses generating reliable cash can play an important role in navigating the turns along the way.
The next several quarters will likely bring more clarity on the trajectory of AI-related capital spending, the path of interest rates, and the resilience of consumer spending. Until that clarity arrives, a measured increase in defensive exposure offers a practical way to stay engaged while reducing vulnerability to any unexpected slowdown in the growth narrative that has dominated recent years.
Ultimately, successful investing combines conviction with flexibility. The companies that continue to produce cash through changing conditions often reward the patience of those willing to own them when they are less fashionable. That perspective feels especially relevant right now.
Whether the AI bull market continues at its previous pace or moderates, the underlying principle remains the same. Portfolios built with attention to free cash flow, quality attributes, and reasonable valuations tend to prove more durable across different environments. The current setup simply makes that principle more visible than it has been for some time.
Taking a defensive stance does not mean expecting the worst. It means preparing for a range of possibilities and ensuring that a meaningful portion of capital is allocated to businesses that can deliver steady results even if the most optimistic scenarios take longer to unfold. In markets that have rewarded concentration for an extended period, that kind of preparation can feel uncomfortable. History suggests it is often worthwhile.
As conditions evolve, the relative attractiveness of different sectors will shift again. The framework of focusing on quality, cash generation, and valuation remains useful regardless of which theme currently captures the most attention. Applying that framework today points toward a greater role for defensive stocks than many portfolios currently reflect.
The opportunity lies not in predicting exact turning points but in positioning for multiple potential paths. Defensive names with strong free cash flow characteristics offer one practical way to do exactly that while still participating in equity markets over the longer term.
